TAK1 Mediates ROS Generation Triggered by the Specific Cephalosporins through Noncanonical Mechanisms.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
14 Dec 2020
Historique:
received: 13 11 2020
revised: 11 12 2020
accepted: 12 12 2020
entrez: 17 12 2020
pubmed: 18 12 2020
medline: 16 3 2021
Statut: epublish

Résumé

It is known that a wide variety of antibacterial agents stimulate generation of reactive oxygen species (ROS) in mammalian cells. However, its mechanisms are largely unknown. In this study, we unexpectedly found that transforming growth factor-β (TGF-β)-activated kinase 1 (TAK1) is involved in the generation of mitochondrial ROS (mtROS) initiated by cefotaxime (CTX), one of specific antibacterial cephalosporins that can trigger oxidative stress-induced cell death. TAK1-deficient macrophages were found to be sensitive to oxidative stress-induced cell death stimulated by H

Identifiants

pubmed: 33327477
pii: ijms21249497
doi: 10.3390/ijms21249497
pmc: PMC7764951
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Cephalosporins 0
Reactive Oxygen Species 0
Mitogen-Activated Protein Kinases EC 2.7.11.24
MAP Kinase Kinase Kinase 5 EC 2.7.11.25
MAP Kinase Kinase Kinases EC 2.7.11.25
MAP kinase kinase kinase 7 EC 2.7.11.25
Map3k5 protein, mouse EC 2.7.11.25
Cefotaxime N2GI8B1GK7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Cancer Res. 2010 Nov 1;70(21):8417-25
pubmed: 20959492
J Biol Chem. 2008 Mar 21;283(12):7657-65
pubmed: 18211888
Cell Rep. 2017 Nov 28;21(9):2447-2457
pubmed: 29186683
Int J Mol Sci. 2016 Nov 09;17(11):
pubmed: 27834853
Nat Rev Immunol. 2013 Sep;13(9):679-92
pubmed: 23954936
JCI Insight. 2018 Feb 8;3(3):
pubmed: 29415881
Sci Transl Med. 2013 Jul 3;5(192):192ra85
pubmed: 23825301
J Biomed Sci. 2015 Sep 18;22:76
pubmed: 26381601
Int J Mol Sci. 2017 Jan 19;18(1):
pubmed: 28106845
Proc Natl Acad Sci U S A. 1991 May 1;88(9):3671-5
pubmed: 2023917
J Biol Chem. 2008 Nov 28;283(48):33080-6
pubmed: 18829460
J Biol Chem. 2017 May 19;292(20):8174-8185
pubmed: 28360100
FEBS Open Bio. 2015 Jun 06;5:492-501
pubmed: 26110105
Trends Immunol. 2013 Jul;34(7):307-16
pubmed: 23664135
Cell Death Dis. 2018 Dec 13;9(12):1193
pubmed: 30546061
J Toxicol Sci. 2019;44(6):435-440
pubmed: 31168030
Cell. 2007 Sep 7;130(5):797-810
pubmed: 17803904
Mol Cell Biol. 2007 Oct;27(20):7273-83
pubmed: 17709393
Immunity. 2012 Jan 27;36(1):43-54
pubmed: 22226633
J Cardiovasc Med (Hagerstown). 2014 Jul;15(7):565-71
pubmed: 23751595
Sci Rep. 2020 Feb 17;10(1):2743
pubmed: 32066809
IUBMB Life. 2012 Oct;64(10):825-34
pubmed: 22941947
Development. 2016 Jun 1;143(11):1981-92
pubmed: 27122166
J Toxicol Sci. 2020;45(4):219-226
pubmed: 32238696
Nat Immunol. 2005 Nov;6(11):1087-95
pubmed: 16186825
J Biol Chem. 2005 Nov 4;280(44):37033-40
pubmed: 16129676
Biol Pharm Bull. 2020;43(10):1562-1569
pubmed: 32999166
Cell Death Dis. 2017 Feb 9;8(2):e2598
pubmed: 28182011
J Antibiot (Tokyo). 2019 Nov;72(11):848-852
pubmed: 31371783
Mol Cell. 2010 Oct 8;40(1):63-74
pubmed: 20932475
J Biol Chem. 1997 Mar 28;272(13):8141-4
pubmed: 9079627
Development. 2006 Apr;133(8):1529-41
pubmed: 16556914
FEBS Lett. 2006 Feb 20;580(5):1320-6
pubmed: 16458303
Antioxid Redox Signal. 2016 Dec 10;25(17):953-964
pubmed: 27245349
J Toxicol Sci. 2020;45(6):349-363
pubmed: 32493877
Diagn Microbiol Infect Dis. 1995 May-Jun;22(1-2):19-33
pubmed: 7587039
J Mol Cell Biol. 2019 Dec 19;11(12):1069-1082
pubmed: 30860577
Semin Cancer Biol. 2006 Dec;16(6):427-35
pubmed: 17081769
Mol Cell Biochem. 2013 May;377(1-2):35-44
pubmed: 23378049

Auteurs

Midori Suzuki (M)

Laboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan.

Yukino Asai (Y)

Laboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan.

Tomohiro Kagi (T)

Laboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan.

Takuya Noguchi (T)

Laboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan.

Mayuka Yamada (M)

Laboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan.

Yusuke Hirata (Y)

Laboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan.

Atsushi Matsuzawa (A)

Laboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH